Secondary Logo

Journal Logo

Most Popular Articles

Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial

Hirschberg, Angelica Lindén; Sánchez-Rovira, Pedro; Presa-Lorite, Jesús; More

Menopause. 27(5):526-534, May 2020.

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause

Fraser, Graeme L.; Lederman, Samuel; Waldbaum, Arthur; More

Menopause. 27(4):382-392, April 2020.

The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)

El Khoudary, Samar R.; Greendale, Gail; Crawford, Sybil L.; More

Menopause. 26(10):1213-1227, October 2019.

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Moral, Eloy; Delgado, Juan L.; Carmona, Francisco; More

Menopause. 25(12):1418-1423, December 2018.

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Miller, Virginia M.; Naftolin, Fredrick; Asthana, Sanjay; More

Menopause. 26(9):1071-1084, September 2019.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.

Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules)

Lobo, Rogerio A.; Liu, James; Stanczyk, Frank Z.; More

Menopause. 26(7):720-727, July 2019.

Physical activity, menopause, and quality of life: the role of affect and self-worth across time

Elavsky, Steriani

Menopause. 16(2):265-271, March 2009.

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial

Archer, David F.; Goldstein, Steven R.; Simon, James A.; More

Menopause. 26(6):611-621, June 2019.

Design and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study with 47 to 55-year-old women's cohort: novel results show menopause-related differences in blood count

Kovanen, Vuokko; Aukee, Pauliina; Kokko, Katja; More

Menopause. 25(9):1020-1032, September 2018.

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Faubion, Stephanie S.; Larkin, Lisa C.; Stuenkel, Cynthia A.; More

Menopause. 25(6):596-608, June 2018.

  • Buy

Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial

El Khoudary, Samar R.; Venugopal, Vidya; Manson, JoAnn E.; More

Menopause. 27(3):255-262, March 2020.

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial

Pinkerton, JoAnn V.; Utian, Wulf H.; Constantine, Ginger D.; More

Menopause. 16(6):1116-1124, November-December 2009.

Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review

Booth, Nancy L.; Piersen, Colleen E.; Banuvar, Suzanne; More

Menopause. 13(2):251-264, March-April 2006.

Effect of rescue fractional microablative CO2 laser on symptoms and sexual dysfunction in women affected by vulvar lichen sclerosus resistant to long-term use of topic corticosteroid: a prospective longitudinal study

Pagano, Tiziana; Conforti, Alessandro; Buonfantino, Cira; More

Menopause. 27(4):418-422, April 2020.

Dietary changes associated with improvement of metabolic syndrome components in postmenopausal women receiving two different nutrition interventions

Rodriguez-Cano, Ameyalli; Mier-Cabrera, Jennifer; Balas-Nakash, Margie; More

Menopause. 22(7):758-764, July 2015.

Association between obesity type and obstructive coronary artery disease in stable symptomatic postmenopausal women: data from the KoRean wOmen'S chest pain rEgistry (KoROSE)

Cho, Jun Hwan; Kim, Hack-Lyoung; Kim, Myung-A; More

Menopause. 26(11):1272-1276, November 2019.

The 2012 Hormone Therapy Position Statement of The North American Menopause Society

The North American Menopause Society

Menopause: The Journal of The North American Menopause Society. 19(3):257-271, March 2012.

Prevalence of osteopenia and osteoporosis in Thai women

Limpaphayom, Khunying Kobchitt; Taechakraichana, Nimit; Jaisamrarn, Unnop; More

Menopause. 8(1):65-69, January 2001.

Age at natural menopause genetic risk score in relation to age at natural menopause and primary open-angle glaucoma in a US-based sample

Pasquale, Louis R.; Aschard, Hugues; Kang, Jae H.; More

Menopause. 24(2):150-156, February 2017.

Adiposity and insulin resistance as mediators between age at menarche and type 2 diabetes mellitus

Liu, Dechen; Zhao, Yang; Liu, Yu; More

Menopause. 27(5):579-585, May 2020.

Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)

Cintron, Dahima; Lahr, Brian D.; Bailey, Kent R.; More

Menopause. 25(2):145-153, February 2018.

Lights on MsFLASH: a review of contributions

Reed, Susan D.; LaCroix, Andrea Z.; Anderson, Garnet L.; More

Menopause. 27(4):473-484, April 2020.

Show: